Vanda Pharmaceuticals reported $493.32M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 566.96M 2.12M
Acorda Therapeutics ACOR:US $ 164.48M 26.01M
Agios Pharmaceuticals AGIO:US $ 1394.76M 327.05M
Akebia Therapeutics AKBA:US $ 137.15M 37.48M
Alnylam Pharmaceuticals ALNY:US $ 755.89M 97.47M
Anika Therapeutics ANIK:US $ 290.06M 3.26M
Arena Pharmaceuticals ARNA:US $ 800.72M 170.36M
Arrowhead Research ARWR:US $ 408.82M 28.07M
AstraZeneca AZN:LN 39744M 24068M
Bluebird Bio BLUE:US $ 870.53M 114.03M
Bristol Myers Squibb BMY:US $ 37213M 405M
Clovis Oncology CLVS:US $ -225.46M 18.48M
Eli Lilly And LLY:US $ 7757M 1312.6M
Enanta Pharmaceuticals ENTA:US $ 399.43M 18.42M
Esperion Therapeutics ESPR:US $ -362705000 58.4M
Halozyme Therapeutics HALO:US $ 281.67M 161.93M
Heron Therapeutics HRTX:US $ 118.84M 41.27M
Insmed INSM:US $ 504.84M 26.21M
Intercept Pharmaceuticals ICPT:US $ -156.03M 47.16M
Lexicon Pharmaceuticals LXRX:US $ 136.6M 630K
Ligand Pharmaceuticals LGND:US $ 812.07M 25.55M
Minerva Neurosciences NERV:US $ 28.08M 8.09M
Moderna Inc MRNA:US 10.12B 3.42B
Novartis NVS:US $ 56771M 2729M
Ptc Therapeutics PTCT:US $ 104.93M 91.65M
Puma Biotechnology PBYI:US $ -10.92M 40.39M
Sangamo Biosciences SGMO:US $ 406.02M 39.44M
Takeda 4502:JP Y 5323935M 24161M
Teva Pharmaceutical TEVA:IT 10.47B 143M
Ultragenyx Pharmaceutical RARE:US $ 933.67M 38.5M
Vanda Pharmaceuticals VNDA:US $ 493.32M 12.1M
Veracyte VCYT:US $ 1107.08M 135.9M